Application of the back-error propagation artificial neural network (BPANN) on genetic variants in the PPAR-γ and RXR-α gene and risk of metabolic syndrome in a Chinese Han population

This study was aimed to explore the associations between the combined effects of several polymorphisms in the PPAR-γ and RXR-α gene and environmental factors with the risk of metabolic syndrome by back-error propagation artificial neural network (BPANN). We established the model based on data gathered from metabolic syndrome patients (n = 1012) and normal controls (n = 1069) by BPANN. Mean impact value (MIV) for each input variable was calculated and the sequence of factors was sorted according to their absolute MIVs. Generalized multifactor dimensionality reduction (GMDR) confirmed a joint effect of PPAR-γ and RXR-α based on the results from BPANN. By BPANN analysis, the sequences according to the importance of metabolic syndrome risk factors were in the order of body mass index (BMI), serum adiponectin, rs4240711, gender, rs4842194, family history of type 2 diabetes, rs2920502, physical activity, alcohol drinking, rs3856806, family history of hypertension, rs1045570, rs6537944, age, rs17817276, family history of hyperlipidemia, smoking, rs1801282 and rs3132291. However, no polymorphism was statistically significant in multiple logistic regression analysis. After controlling for environmental factors, A1, A2, B1 and B2 (rs4240711, rs4842194, rs2920502 and rs3856806) models were the best models (cross-validation consistency 10/10, P = 0.0107) with the GMDR method. In conclusion, the interaction of the PPAR-γ and RXR-α gene could play a role in susceptibility to metabolic syndrome. A more realistic model is obtained by using BPANN to screen out determinants of diseases of multiple etiologies like metabolic syndrome.

[1]  A. Piwońska,et al.  Socioeconomic factors and the risk of metabolic syndrome in the adult Polish population: the WOBASZ study. , 2012, Kardiologia polska.

[2]  L. Dongxia,et al.  Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[3]  Enzo Grossi,et al.  Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks , 2010, BMC Medical Genomics.

[4]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[5]  S. Yamaguchi,et al.  Effects of Six Functional SNPs on the Urinary 8-Isoprostane Level in a General Japanese Population; Shimane COHRE Study , 2011, Disease markers.

[6]  Mohammad Ghodsi,et al.  Comparison of artificial neural network and logistic regression models for prediction of mortality in head trauma based on initial clinical data , 2005, BMC Medical Informatics Decis. Mak..

[7]  Ling Zhou,et al.  Genetic variants in peroxisome proliferator-activated receptor-γ and retinoid X receptor-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population. , 2011, Diabetes technology & therapeutics.

[8]  David Curtis,et al.  Comparison of artificial neural network analysis with other multimarker methods for detecting genetic association , 2007, BMC Genetics.

[9]  M. Matsuda,et al.  Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.

[10]  A. Onat,et al.  Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation. , 2002, Atherosclerosis.

[11]  Q. Hua,et al.  Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. , 2009, Archives of medical research.

[12]  R. Andersson,et al.  Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease , 2010, Pancreatology.

[13]  J V Tu,et al.  Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. , 1996, Journal of clinical epidemiology.

[14]  P. Amouyel,et al.  Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. , 2005, Diabetes.

[15]  Ali H Mokdad,et al.  Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.

[16]  Jun Zhu,et al.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. , 2007, American journal of human genetics.

[17]  M. Bragt,et al.  Peroxisome proliferator-activated receptors and the metabolic syndrome , 2008, Physiology & Behavior.

[18]  C. Dina,et al.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. , 2001, Human molecular genetics.

[19]  Ikuo Saito,et al.  Metabolic syndrome: recent prevalence in East and Southeast Asian populations. , 2007, Asia Pacific journal of clinical nutrition.

[20]  Xiao-guang Yang,et al.  Association between adiponectin and metabolic syndrome in older adults from major cities of China. , 2010, Biomedical and environmental sciences : BES.

[21]  T. Assimes,et al.  Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study , 2012, Cardiovascular Diabetology.

[22]  L. Niskanen,et al.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.

[23]  Shinji Kihara,et al.  Adiponectin: a key adipocytokine in metabolic syndrome. , 2006, Clinical science.

[24]  Juan Du,et al.  Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: a case-control study of a Chinese Han population. , 2012, Archives of medical research.

[25]  J. Lehmann,et al.  An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.